10 years of Making More Health
10 years ago, Boehringer Ingelheim started the social initiative Making More Health together with our partner Ashoka. Watch the video here to learn more.
Search
COVID-19 Material donations in Germany
Boehringer Ingelheim donates protective equipment and disinfectants to authorities and social institutions at the company's German sites during COVID-19.
COVID-19 Bill and Melinda Gates Foundation
We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
Patient Safety
Patient Safety@ Boehringer Ingelheim Pharmacovigilance
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.
Our-position
12 years ago, several leading German companies including Boehringer Ingelheim came together to launch Afrika Kommt! Learn more about it here.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim supports carbon emissions reduction projects by partnering with ClimateSeed. Click here to find out more information about this.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.
COVID-19 Supply Chain and Production
Supplying patients and customers with their medicines is our highest priority. Learn about COVID-19's impact on our supply chain and production here.
Kobe
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Kobe site.
garbage game
Learn more about marine pollution and find out how long it takes for garbage to dissolve in the oceans.
Yamagata
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Yamagata site.
COVID-19 Germany - Sports videos for staying fit at home
Aline Nichtern, Head of the Boehringer Ingelheim Sports Centre, offers an online sports programme for all home office employees. Click here to learn more.
Xochimilco
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Xochimilco site.
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
The METAmorphosis
At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic. Learn more.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Ingelheim
The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. Click here to find out and learn more about our headquarters.
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
COVID-19 In Colombia we support integrally
At Boehringer Ingelheim Colombia, we are caring for those in the most vulnerable situations during COVID-19. Click here to learn more about our work.